Inflammatory Immune Responses in Patients with Tick-Borne Encephalitis: Dynamics and Association with the Outcome of the Disease.
adaptive immune responses
chemokines
cytokines
immunopathogenesis
inflammatory mediators
innate immune responses
outcome
post-encephalitic syndrome
tick-borne encephalitis
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
31 Oct 2019
31 Oct 2019
Historique:
received:
26
09
2019
revised:
17
10
2019
accepted:
29
10
2019
entrez:
6
11
2019
pubmed:
7
11
2019
medline:
7
11
2019
Statut:
epublish
Résumé
Information on the association of inflammatory immune responses and disease outcome after tick-borne encephalitis (TBE) is limited. In the present study, we assessed the levels of 24 cytokines/chemokines associated with innate and adaptive immune responses in matched serum and cerebrospinal fluid (CSF) samples of 81 patients at first visit, and in serum at follow-up time points. Serum levels of several cytokines/chemokines obtained during the meningoencephalitic phase of TBE differed compared to the levels at a follow-up visit 2 months later; several significant differences were also found in cytokine/chemokine levels in serum at 2 months compared to the last time point, 2-7 years after acute illness. Cytokines/chemokines levels in CSF or serum obtained at the time of acute illness or serum levels obtained 2 months after the onset of TBE did not have predictive value for an unfavorable outcome 2-7 years later. In contrast, serum levels of mediators associated with Th17 responses were lower in patients with unfavorable outcome whereas those associated with other adaptive or innate immune responses were higher at the last visit in those with an unfavorable outcome. These findings provide new insights into the immunopathogenesis of TBE and implicate inflammatory immune responses with post-encephalitic syndrome years after the initial infection.
Identifiants
pubmed: 31683598
pii: microorganisms7110514
doi: 10.3390/microorganisms7110514
pmc: PMC6920956
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : P3-0296
Organisme : Global Lyme Alliance and MGH-ECOR
ID : No grant number
Références
J Med Virol. 2015 May;87(5):885-92
pubmed: 25675945
Clin Infect Dis. 1999 Apr;28(4):882-90
pubmed: 10825054
Nat Genet. 2010 Feb;42(2):123-7
pubmed: 20062062
Nat Rev Immunol. 2014 Sep;14(9):585-600
pubmed: 25145755
Adv Med Sci. 2011;56(2):311-7
pubmed: 22008312
J Infect Dis. 2004 Nov 1;190(9):1618-26
pubmed: 15478067
Infect Ecol Epidemiol. 2011;1:null
pubmed: 22957110
J Clin Med. 2019 May 22;8(5):null
pubmed: 31121969
Nat Genet. 2007 Nov;39(11):1329-37
pubmed: 17952073
Travel Med Infect Dis. 2018 Nov - Dec;26:25-31
pubmed: 30296483
Clin Vaccine Immunol. 2013 Oct;20(10):1578-84
pubmed: 23945160
Acta Neurol Scand. 2007 Feb;115(2):109-14
pubmed: 17212614
Arch Med Sci. 2018 Mar;14(2):313-320
pubmed: 29593804
J Neuroinflammation. 2017 Jun 24;14(1):126
pubmed: 28646884
Ticks Tick Borne Dis. 2018 Jul;9(5):1137-1142
pubmed: 29705691
PLoS Genet. 2008 Mar 28;4(3):e1000041
pubmed: 18369459
J Neuroinflammation. 2016 Oct 18;13(1):273
pubmed: 27756335
Neurosci Lett. 2010 Mar 31;473(1):48-51
pubmed: 20153811
J Gen Virol. 2009 Aug;90(Pt 8):1781-94
pubmed: 19420159
Clin Exp Immunol. 2003 Jan;131(1):148-54
pubmed: 12519399
Cent Eur J Immunol. 2017;42(2):218-222
pubmed: 28860941
Pediatr Infect Dis J. 2016 Sep;35(9):961-6
pubmed: 27187756
Nature. 2008 Jun 19;453(7198):1051-7
pubmed: 18563156
Eur J Neurol. 2017 Oct;24(10):1214-e61
pubmed: 28762591
Pol Merkur Lekarski. 2001 Jul;11(61):26-8
pubmed: 11579825
J Neuroinflammation. 2018 Apr 20;15(1):115
pubmed: 29678185
Ticks Tick Borne Dis. 2018 Feb;9(2):369-378
pubmed: 29275872
Science. 2006 Dec 1;314(5804):1461-3
pubmed: 17068223
Clin Infect Dis. 2014 Feb;58(3):372-80
pubmed: 24218102
World J Clin Cases. 2015 May 16;3(5):430-41
pubmed: 25984517